Merck Balks At Class Bid In Fosamax Case

Law360, New York (September 17, 2007, 12:00 AM EDT) -- Already facing a mountain of suits over Fosamax, Merck has protested a recent bid for certification of a dental monitoring class for patients taking the osteoporosis drug, arguing that the group has been unable to make a case that would justify the move.

On Friday, lawyers for Merck & Co. Inc. filed their objection in the U.S. District Court for the Southern District of New York, contending that plaintiffs’ recent request for class certification would be an inappropriate remedy under the law.

“Plaintiffs seek unprecedented class...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.